Investor Menu

Corporate Profile

Corporate Profile

Plus Therapeutics (PSTV on Nasdaq) is a U.S. clinical-stage pharmaceutical company, backed by talented executives and a nationwide network of scientists, engineers and physicians.

With a hybrid virtual drug development model, we are well-positioned to be capital efficient, enhance operational efficiencies, decrease costs, and accelerate product development. We are headquartered in Austin, Texas, with additional laboratories and state-of-the-art clean rooms in San Antonio, Texas in order to undertake key preclinical and other development work. 

Our location provides us with many strategic advantages, including proximity to world-class cancer institutions and researchers – as well as the ability to qualify and apply for funding through the Cancer Prevention and Research Institute of Texas (CPRIT).

Press Releases

Reports & Filings

Stock information

Governance

Meetings & Proxy Materials

Annual Stockholder Meeting

Date: Tuesday, June 18, 2019
Time: 9 am PST
Location: PLUS THERAPEUTICS, Inc.
12526 High Bluff Drive, Suite 300,
San Diego, CA 92130

Electronic Proxy & Stockholder Material

PLUS THERAPEUTICS is pleased to offer stockholders the option of electronic delivery of its proxy statements and annual 10-K for the 2019 annual meeting. Electronic delivery benefits PLUS THERAPEUTICS and its stockholders through the reduction of printing costs and paper usage, thereby benefiting the environment. We encourage you to enroll.